- Previous Close
24.70 - Open
24.76 - Bid 24.62 x --
- Ask 24.70 x --
- Day's Range
24.50 - 24.76 - 52 Week Range
20.94 - 39.90 - Volume
738,914 - Avg. Volume
460,675 - Market Cap (intraday)
2.953B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
117.43 - EPS (TTM)
0.21 - Earnings Date Mar 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 9, 2022
- 1y Target Est
31.30
Saudi Pharmaceutical Industries and Medical Appliances Corporation develops, manufactures, and markets of medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middles East, Egypt, and Morocco. It operates through Pharmaceutical Manufacturing, Trading and Distribution Services, and Healthcare Services segments. The company is involved in the sale, marketing, and distribution of pharmaceutical, veterinary, medical equipment, and cosmetics products; and operates and maintains healthcare facilities. In addition, it manufactures human medicines, and wholesales and retails of medicines and related products. Further, the company engages in the research and development of medical science activities, and investment business in related industries. The company was incorporated in 1986 and is headquartered in Buraydah, the Kingdom of Saudi Arabia.
www.spimaco.com.sa--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 2070.SR
View MorePerformance Overview: 2070.SR
Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2070.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2070.SR
View MoreValuation Measures
Market Cap
2.95B
Enterprise Value
4.18B
Trailing P/E
117.62
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.76
Price/Book (mrq)
2.14
Enterprise Value/Revenue
2.49
Enterprise Value/EBITDA
16.56
Financial Highlights
Profitability and Income Statement
Profit Margin
1.46%
Return on Assets (ttm)
1.75%
Return on Equity (ttm)
2.09%
Revenue (ttm)
1.68B
Net Income Avi to Common (ttm)
24.54M
Diluted EPS (ttm)
0.21
Balance Sheet and Cash Flow
Total Cash (mrq)
277.62M
Total Debt/Equity (mrq)
98.77%
Levered Free Cash Flow (ttm)
-354.87M